Rafii Shahin, Avecilla Scott, Shmelkov Sergey, Shido Koji, Tejada Rafael, Moore Malcolm A S, Heissig Beate, Hattori Koichi
Cornell University Medical College, New York, New York 10021, USA.
Ann N Y Acad Sci. 2003 May;996:49-60. doi: 10.1111/j.1749-6632.2003.tb03232.x.
The mechanism by which angiogenic factors recruit bone marrow (BM)-derived quiescent endothelial and hematopoietic stem cells (HSCs) is not known. Here, we report that functional vascular endothelial growth factor receptor-1 (VEGFR1, Flt-1) is expressed on a subpopulation of human CD34(+) and mouse Lin-Sca-1(+)c-Kit(+) BM-repopulating stem cells, conveying signals for recruitment of HSCs and reconstitution of hematopoiesis. Inhibition of VEGFR1 signaling, but not VEGFR2 (Flk-1, KDR), blocked HSC cell cycling, differentiation and hematopoietic recovery after BM suppression, resulting in the demise of the treated mice. Plasma elevation of placental growth factor (PlGF), which signals through VEGFR1, but not VEGFR2, restored hematopoiesis during the early and late phases following BM suppression. The mechanism whereby PlGF enhanced early phases of BM recovery was mediated directly through rapid chemotaxis of readily available VEGFR1(+) BM-repopulating and progenitor cells. The late phase of hematopoietic recovery was driven by PlGF-induced upregulation of matrix metalloproteinase-9 (MMP-9) in the BM, mediating the release of soluble Kit-ligand (sKitL). sKitL increased proliferation and motility of HSCs and progenitor cells, thereby augmenting hematopoietic recovery. PlGF promotes recruitment of VEGFR1(+) HSCs from a quiescent to a proliferative microenvironment within the BM, favoring differentiation, mobilization, and reconstitution of hematopoiesis.
血管生成因子募集骨髓(BM)来源的静止内皮细胞和造血干细胞(HSC)的机制尚不清楚。在此,我们报告功能性血管内皮生长因子受体-1(VEGFR1,Flt-1)在人CD34(+)和小鼠Lin-Sca-1(+)c-Kit(+) BM重建干细胞的亚群上表达,传递募集HSC和重建造血的信号。抑制VEGFR1信号传导而非VEGFR2(Flk-1,KDR)可阻断BM抑制后HSC的细胞周期、分化和造血恢复,导致受试小鼠死亡。通过VEGFR1而非VEGFR2发出信号的胎盘生长因子(PlGF)的血浆水平升高,可在BM抑制后的早期和晚期恢复造血。PlGF增强BM恢复早期阶段的机制是直接通过易于获得的VEGFR1(+) BM重建和祖细胞的快速趋化作用介导的。造血恢复的晚期阶段是由PlGF诱导BM中基质金属蛋白酶-9(MMP-9)上调驱动的,介导可溶性Kit配体(sKitL)的释放。sKitL增加HSC和祖细胞的增殖和运动能力,从而增强造血恢复。PlGF促进VEGFR1(+) HSC从BM内的静止微环境募集到增殖微环境,有利于造血的分化、动员和重建。